Stock Price Forecast. Analyst Recommendations . 100% FREE. The 4 analysts offering 12-month price forecasts for Magenta Therapeutics Inc have a median target of 16.50, with a high estimate of 22.00 and a low estimate of 15.00. The average price target represents a 60.61% upside from the last price of $11.00. Stock Forecast Guess' Guidewire Software Guidewire Software Stock Forecast Guild Gulf Resources Gulfport Energy GWG H & R Block Stock Forecast H.B. The best long-term & short-term ObsEva SA. In this MGTA stock guide, we'll address key questions about MGTA, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell … STARWOOD PROPERTY TRUST, INC. is expected* to report earnings on 05/06/2021 before market open. Past Monthly Recommendations. Zillow Group Is Ready To Rocket Higher 3 Buy the Dip Candidates to Add on Market Weakness. The average price target is $17.67, with a high forecast of $22.00 and a low forecast of $15.00. Volume today is below average. The MGTA stock was … Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. Magenta Therapeutics Inc (MGTA) stock is trading at $6.69 as of 11:10 AM on Monday, Nov 9, an increase of $0.39, or 6.19% from the previous closing price of $6.30. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for … Ford is betting that solid-state batteries will cut EV costs. ET. ObsEva SA. A number of institutional investors and hedge funds have recently modified their holdings of MGTA. Analyst Recommendations . The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Magenta Therapeutics, Inc. Common Stock (MGTA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. DOW 34,230.34. The median estimate represents a +38.89% increase from the last price of 11.88. This Buy consensus rating has held steady for over two years. Magenta Therapeutics Inc (MGTA) - Stock, Realtime Charts, Screeners, News, Price Alerts and Many More. Magenta Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Analysts forecast that Magenta Therapeutics will post -1.74 EPS for the current year. GM … Abeona Therapeutics stock price target raised to $14 from $8 at Maxim Group. Insiders buying/selling: Magenta Therapeutics (NASDAQ:MGTA) In the past three months, Magenta Therapeutics insiders have not sold or bought any company stock. Buy The current consensus among 4 polled investment analysts is to buy stock in Magenta Therapeutics. The median estimate represents a +59.57% increase from the last price of 10.34. Karuna Therapeutics stock price target raised to $150 from $116 at Mizuho. What this means: Magenta Therapeutics Inc (MGTA) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. As a group, sell-side analysts forecast that Magenta Therapeutics will post -1.74 EPS for the current fiscal year. List Status Active Exchange Stuttgart Stock Exchange (XSTU) Ticker 3MT ISIN US55910K1088 Security Type Equity Share Sector Pharmaceuticals Incorporated United States Market Cap 357m USD Magenta Therapeutics Inc … Woodseer Dividend Forecasting » Stock Exchanges » NASDAQ Stock Market » Magenta Therapeutics Inc - Ordinary Shares. If so, you came to the right place. About the Magenta Therapeutics, Inc. stock forecast. Stock Price Forecast. Customizable interactive chart for Magenta Therapeutics Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. View BEAM's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Here’s what analysts think will happen to its price in the coming time. MAGENTA THERAPEUTICS, INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: MGTA | Nasdaq As of 2021 April 17, Saturday current price of MGTA stock is 10.940$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Magenta Therapeutics stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Looking to buy or sell Magenta Therapeutics (MGTA)? JPMorgan Chase & Co. increased its stake in Magenta Therapeutics by 232.4% during the fourth quarter. Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Magenta Therapeutics Inc stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. ET by Tomi Kilgore. The advice algorithm takes into account all of Magenta Therapeutics' available fundamental , technical, and predictive indicators you will find on this site. The 4 analysts offering 12-month price forecasts for Magenta Therapeutics Inc have a median target of 16.50, with a high estimate of 22.00 and a low estimate of 15.00. Stock Price Forecast. So far 93,771 shares have traded compared to average volume of 174,639 shares. Analyst Recommendations . Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to … MGTA: Get the latest Magenta Therapeutics stock price and detailed information including MGTA news, historical charts and realtime prices. Here is what you'll … Magenta Therapeutics Inc. (NASDAQ: MGTA) is 38.14% higher on its value in year-to-date trading and has touched a low of $6.03 and a high of $14.20 in the current 52-week trading range. MGTA's 51 means that it ranks higher than 51% of stocks. ET by Tomi Kilgore. Magenta Therapeutics Inc Ordinary Shares. Never miss a profitable trade. QQQ 329.03. The stock has traded between $6.57 and $7.00 so far today. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Only 10.90% of the stock of Magenta Therapeutics is held by insiders. Interested in getting the full scoop on MGTA, including earnings and dividends, stock forecast, buy or sell analysis and key stats? The median estimate represents a +43.65% increase from the last price of 10.79. Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset via stem cell transplant to more patients, today highlighted progress across its stem cell mobilization and collection and targeted conditioning programs, and set expectations for 2021. Limited Time Only . Macroaxis provides Magenta Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 3MT positions.